• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

University of Queensland’s Aphasia Treatment Programme Goes Online

Share:

March 13, 2023

The University of Queensland is now expanding its aphasia therapy programme to reach more patients living in rural and regional areas.

A year since it was launched at Metro North Health’s Surgical Treatment and Rehabilitation Service in Brisbane, the Comprehensive High-Dose Aphasia Treatment (CHAT) programme will be tried out in seven hospitals and health service sites in Queensland, New South Wales and South Australia.

Its online version, TeleCHAT, will also be made available as an option for people at home. Delivered via videoconferencing software, TeleCHAT is currently being researched for its usability, feasibility, and acceptability. UQ shared that based on early results, the online programme has “significantly” increased access to aphasia therapy for those in rural and regional areas.

WHY IT MATTERS

According to Professor David Copland, director of UQ’s Queensland Aphasia Research Centre, they are expanding the CHAT programme to help deliver the best and most appropriate therapy for many aphasia patients in Australia. At present, over 140,000 Australians are dealing with aphasia, a language disorder that affects how a person communicates following a stroke or head injury.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Our clinicians and researchers will assess the clinical outcomes and cost-effectiveness of the CHAT program across multiple health settings and compare it with aphasia care currently being provided,” Prof Copland added.

The CHAT program is supported by a A$1 million ($650,000) grant from the National Health and Medical Research Council. It includes 50 hours of intensive therapy delivered over eight weeks by speech pathologists with support from aphasia researchers.

Source: MobihealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • New Year, New Codes: Best Practices for Keeping Your Chargemaster Up-To-DateNew Year, New Codes: Best Practices for Keeping Your Chargemaster Up-To-Date
  • Marijuana Company of America Acquires Interest in Licensed California Manufacturing & Distribution CompanyMarijuana Company of America Acquires Interest in Licensed California Manufacturing & Distribution Company
  • USDA Announces Dozens of Grants to Support Rural Telehealth RolloutsUSDA Announces Dozens of Grants to Support Rural Telehealth Rollouts
  • Glaucoma Pharmaceutical Market Research Report 2022 By Manufacturers, Regions, Types and ApplicationsGlaucoma Pharmaceutical Market Research Report 2022 By Manufacturers, Regions, Types and Applications
  • AI in healthcare: Not human versus machine, human plus machineAI in healthcare: Not human versus machine, human plus machine
  • Improving Medical Devices with Force Sensing TechnologyImproving Medical Devices with Force Sensing Technology
  • Surge Raises $2.6M for Blood Test to Predict Post-Surgery ComplicationsSurge Raises $2.6M for Blood Test to Predict Post-Surgery Complications
  • Gryphon Investors Announces Majority Investment in LEARN BehavioralGryphon Investors Announces Majority Investment in LEARN Behavioral

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications